RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery

NCT02065375 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation and Pain Following Ocular Surgery

Interventions

DRUG: Omaveloxolone Ophthalmic Suspension 1.0%
DRUG: Omaveloxolone Opthalmic Suspension 0.5%
DRUG: Placebo

Sponsor

Biogen

Collaborators

[object Object]